A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris

Trial Profile

A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Jul 2017

At a glance

  • Drugs Minocycline (Primary)
  • Indications Acne; Acne vulgaris
  • Focus Therapeutic Use
  • Acronyms OPAL
  • Sponsors BioPharmX Corporation
  • Most Recent Events

    • 13 Jul 2017 According to a BioPharmX Corporation, results will be presented at the Dermatology Education Foundation's Essential Resource Meeting, DERM 2017.
    • 22 Jun 2017 According to a BioPharmX Corporation media release, data from this trial presented to the investor community.
    • 22 Jun 2017 Results published in the BioPharmX Corporation Media Release
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top